The researchers Pier Paolo Scaglioni and Georgia Konstantinidou said that an experimental nature of the drug called BEZ235 with the combination of low-dose radiation successfully eliminated in mice with non-small cell lung cancer (NSCL).
Dr. Scaglioni said: "These early results indicate that the drug combination of radiation may be able to effectively treat patients with lung cancer."
Newer news items:
- For some early stage lung cancer, new treatment options
- More Common in Public Hospitals:Delays in Lung Cancer Care
- There is a risk, prophylactic cranial radiation therapy in patients with lung cancer
Older news items:
- The researchers focus on joint development of mesothelioma drug
- Hispanic Americans are not easy to Cancer
- 60 inspiring miles to raise money for breast cancer research through Susan G. Komen for the Cure
- Placenta Growth Factor & Mesothelioma Prognosis
- Elks Lodge displays car show for cancer research